November 20, 2026

High Honor for Heidelberg Medical Ethicist: Professor Eva Winkler Elected to the Leopoldina

High Honor for Heidelberg Medical Ethicist: Professor Eva Winkler Elected to the Leopoldina

The German National Academy of Sciences Leopoldina has elected Professor Eva Winkler to its Class IV: Humanities, Social and Behavioural Sciences. As a member of the Leopoldina, the Professor of Translational Medical Ethics at the Heidelberg Faculty of Medicine at Heidelberg University will contribute to the Academy’s scientific position statements and policy recommendations. Her ongoing work focuses on ethical issues and challenges in medical research, clinical care, and public health.

Professor Eva Winkler formally received her membership certificate on Wednesday, 18 November 2026, during the Leopoldina Symposium “Climate Crisis and Society” in Halle (Saale), Germany. As an expert in medical ethics, she has been elected to the Academy’s Section for Philosophy of Science within the Class IV: Humanities, Social and Behavioural Sciences. An election to the German National Academy of Sciences is among the highest distinctions in academic research. The Leopoldina brings together researchers who have made outstanding contributions in their respective fields and who contribute their expertise to evidence-based advice for policymakers and society.

“New developments in medicine, from genome sequencing and personalized gene therapies to the use of artificial intelligence and the digitalization of health data, offer tremendous opportunities for patients. At the same time, however, they also raise complex ethical questions,” says Professor Winkler. Within the Leopoldina’s committees and working groups, she will engage in scientific exchange with members from a wide range of disciplines on these and other important issues shaping the future. In addition to contributing to statements and discussion papers, she will represent the Academy at national and international events. Beginning in 2027, Professor Winkler will also serve on the Leopoldina’s Standing Committee for Life Sciences, where the social relevance of research questions concerning life sciences are discussed from an interdisciplinary perspective. “I am delighted to contribute to ensuring that ethical considerations are consistently integrated into societal and political debates, particularly when it comes to modern biomedical research, patient care, and public health,” Professor Winkler says.

Professor Eva Winkler (centre) at the ceremonial presentation of the certificate with Professor Bettina Rockenbach (left), President of the German National Academy of Sciences Leopoldina, and Franziska Hornig, Secretary General of the Leopoldina. Credit: Markus Scholz | Leopoldina

The photograph may be used only in connection with journalistic coverage of the subject matter of this press release and only if the photo credit is provided. The photograph may not be altered or used in a misleading manner, may not be used in an unrelated context or environment, and may not be passed on to third parties or archived.

About Eva Winkler

Eva Winkler is Professor of Translational Medical Ethics and Director of the Institute for Medical and Data Ethics at the Heidelberg Faculty of Medicine at Heidelberg University. She also serves as Vice Dean for Digitalization at the Faculty and is a member of the Executive Board of the National Center for Tumor Diseases (NCT) Heidelberg. She practices as a senior physician at the Department of Medical Oncology at Heidelberg University Hospital. Since 2024, she has been a member and Deputy Chair of the German Ethics Council (Deutscher Ethikrat). Since 2025, she has also served as Founding Director of Heidelberg University’s Camilla and Georg Jellinek Center for Ethics.

The German National Academy of Sciences Leopoldina

The German National Academy of Sciences Leopoldina provides independent, science-based advice to policymakers and society on both national and international levels. To this end, its members develop interdisciplinary statements grounded on scientific evidence. The Leopoldina has approximately 1,700 members from more than 30 countries and brings together expertise from nearly all fields of research. To date, it has published more than 350 statements and discussion papers. New members are elected exclusively on the nomination of existing members. Selection takes place through a multi-stage review process in which the scientific excellence of each nominee is thoroughly assessed.

Further Information Online

Institute for Medical and Data Ethics

Our latest News

discover more
DKFZ Researchers Among the Top in Citations

DKFZ Researchers Among the Top in Citations

13 researchers who conduct research at the German Cancer Research Center (DKFZ) or lead joint bridge departments with the DKFZ have reached the very top in 2026: They rank among the top 1 percent of the world’s most-cited researchers in their respective fields. Scientists whose work is cited particularly frequently by their peers are considered […]

Universität Heidelberg with 16 “Highly Cited Researchers”

Universität Heidelberg with 16 “Highly Cited Researchers”

International evaluation names researchers whose publications have been most cited worldwide 16 researchers from Heidelberg University feature on the recently published list of “Highly Cited Researchers”. This international evaluation names researchers whose publications have been cited most frequently worldwide in their respective field or who have an outstanding track-record of publications across several disciplines. The […]

mRNA Booster for Cellular Immunotherapy Against Aggressive Brain Tumors

mRNA Booster for Cellular Immunotherapy Against Aggressive Brain Tumors

A team led by researchers at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) has developed a new approach to more effectively direct immune cells against glioblastomas. In experimental models, they were able to show that a targeted mRNA vaccine significantly increases the potency of therapeutic immune cells. The vaccine […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp